Mixed safety results for RA meds in pregnancy

Methotrexate is not recommended for use, but sulfasalazine and hydroxychloroquine are fine for pregnant women with rheumatoid arthritis, according to a US study.

The review of safety evidence published in the journal Therapeutic Advances in Musculoskeletal Disease says rheumatologists are a critical source of support for female RA patients concerned about the potential risks of their RA medication during pregnancy.  

DMARDs like sulfasalazine and hydroxychloroquine have come up with no reported risk, while there was inadequate data for anakinra, abatacept, tocilizumab and tofacitinib.